Cyproheptadine Hydrochloride & Tricholine Citrate Syrup
Cyproheptadine Syrup – Cyponote 200 ml
Dosage Form : Syrup
Moxinote-CV 625 is a combination antibiotic formulation containing Amoxicillin and Potassium Clavulanate. It is prescribed to manage different types of bacterial infections based on the patient’s condition and the advice of a qualified medical practitioner. This formulation combines Amoxicillin, a penicillin-class antibiotic, with Clavulanic Acid, which helps overcome certain bacterial resistance mechanisms and enhances its antibacterial activity against susceptible organisms.
Amoxicillin works by interfering with the formation of bacterial cell walls, helping to eliminate infection-causing bacteria. Potassium Clavulanate acts as a beta-lactamase inhibitor, protecting Amoxicillin from breakdown by certain enzymes produced by resistant bacteria. Together, these ingredients provide broader antibacterial coverage against susceptible bacterial strains.
Moxinote-CV 625 may be prescribed for several bacterial infections, including respiratory tract infections, sinus infections, ear infections, urinary tract infections, and skin and soft tissue infections. Its use depends on the type of infection, bacterial susceptibility and the patient’s medical condition.
The tablet formulation provides a convenient option for oral administration as part of a prescribed treatment schedule.For safe use, patients should follow the treatment schedule and dosage specified by their doctor. The full course should be taken as prescribed, and self-medication should be avoided.
Moxinote-CV 625 is an option for responsible bacterial infection management when clinically indicated. Proper antibiotic selection, adherence to treatment instructions and medical supervision help support effective treatment while reducing the risk of antibiotic resistance.
Reviews
There are no reviews yet.